![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PLXNA4 | Human | (-)-citrinin | decreases expression | EXP | | 6480464 | Citrinin results in decreased expression of PLXNA4 mRNA | CTD | PMID:36460223 | PLXNA4 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Plxna4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLXNA4 mRNA | CTD | PMID:36331819 | PLXNA4 | Human | 1,2-dichloroethane | decreases expression | ISO | Plxna4 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PLXNA4 mRNA | CTD | PMID:28960355 | PLXNA4 | Human | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of PLXNA4 mRNA | CTD | PMID:20170705 and PMID:26865667 | PLXNA4 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of PLXNA4 mRNA | CTD | PMID:29097150 | PLXNA4 | Human | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of PLXNA4 mRNA | CTD | PMID:18936297 | PLXNA4 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of PLXNA4 mRNA | CTD | PMID:30165855 | PLXNA4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLXNA4 mRNA | CTD | PMID:32109520 and PMID:33387578 | PLXNA4 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | PLXNA4 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLXNA4 mRNA more ... | CTD | PMID:28628672 | PLXNA4 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PLXNA4 mRNA | CTD | PMID:28628672 | PLXNA4 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PLXNA4 gene | CTD | PMID:27153756 | PLXNA4 | Human | benzo[a]pyrene | increases mutagenesis | EXP | | 6480464 | Benzo(a)pyrene results in increased mutagenesis of PLXNA4 gene | CTD | PMID:25435355 | PLXNA4 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PLXNA4 5' UTR | CTD | PMID:27901495 | PLXNA4 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PLXNA4 exon and Benzo(a)pyrene results in increased methylation of PLXNA4 promoter | CTD | PMID:27901495 | PLXNA4 | Human | benzo[a]pyrene | decreases methylation | ISO | Plxna4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of PLXNA4 intron | CTD | PMID:27901495 | PLXNA4 | Human | benzo[a]pyrene | increases methylation | ISO | Plxna4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of PLXNA4 exon | CTD | PMID:27901495 | PLXNA4 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PLXNA4 mRNA | CTD | PMID:20170705 | PLXNA4 | Human | bisphenol A | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PLXNA4 mRNA | CTD | PMID:32156529 | PLXNA4 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA4 gene | CTD | PMID:31601247 | PLXNA4 | Human | bisphenol A | increases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PLXNA4 mRNA | CTD | PMID:29097150 and PMID:30816183 | PLXNA4 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PLXNA4 mRNA | CTD | PMID:27685785 | PLXNA4 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLXNA4 mRNA | CTD | PMID:28628672 | PLXNA4 | Human | bisphenol F | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PLXNA4 mRNA | CTD | PMID:30951980 | PLXNA4 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of PLXNA4 mRNA | CTD | PMID:26079696 | PLXNA4 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of PLXNA4 mRNA | CTD | PMID:25979313 | PLXNA4 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PLXNA4 gene] | CTD | PMID:28238834 | PLXNA4 | Human | chlorpyrifos | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PLXNA4 mRNA | CTD | PMID:37019170 | PLXNA4 | Human | clobetasol | decreases expression | ISO | Plxna4 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of PLXNA4 mRNA | CTD | PMID:27462272 | PLXNA4 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of PLXNA4 mRNA | CTD | PMID:19320972 | PLXNA4 | Human | Cuprizon | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of PLXNA4 mRNA | CTD | PMID:26577399 | PLXNA4 | Human | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PLXNA4 mRNA | CTD | PMID:25047013 | PLXNA4 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLXNA4 mRNA more ... | CTD | PMID:28628672 | PLXNA4 | Human | diquat | decreases expression | ISO | Plxna4 (Mus musculus) | 6480464 | Diquat results in decreased expression of PLXNA4 mRNA | CTD | PMID:36851058 | PLXNA4 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXNA4 mRNA | CTD | PMID:27188386 | PLXNA4 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PLXNA4 mRNA | CTD | PMID:29803840 | PLXNA4 | Human | epoxiconazole | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of PLXNA4 mRNA | CTD | PMID:35436446 | PLXNA4 | Human | ethanol | affects splicing | ISO | Plxna4 (Mus musculus) | 6480464 | Ethanol affects the splicing of PLXNA4 mRNA | CTD | PMID:30319688 | PLXNA4 | Human | ethanol | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | Ethanol results in increased expression of PLXNA4 mRNA | CTD | PMID:30319688 | PLXNA4 | Human | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of PLXNA4 mRNA | CTD | PMID:21867686 | PLXNA4 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA4 gene | CTD | PMID:31601247 | PLXNA4 | Human | genistein | affects expression | EXP | | 6480464 | Genistein affects the expression of PLXNA4 mRNA | CTD | PMID:26865667 | PLXNA4 | Human | genistein | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | Genistein results in increased expression of PLXNA4 mRNA | CTD | PMID:32186404 | PLXNA4 | Human | gentamycin | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PLXNA4 mRNA | CTD | PMID:33387578 | PLXNA4 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLXNA4 mRNA more ... | CTD | PMID:28628672 | PLXNA4 | Human | lead(0) | affects methylation | EXP | | 6480464 | Lead affects the methylation of PLXNA4 gene | CTD | PMID:24519525 | PLXNA4 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of PLXNA4 mRNA | CTD | PMID:28001369 | PLXNA4 | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PLXNA4 mRNA | CTD | PMID:24810058 | PLXNA4 | Human | paracetamol | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PLXNA4 mRNA | CTD | PMID:33387578 | PLXNA4 | Human | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of PLXNA4 mRNA | CTD | PMID:25812627 | PLXNA4 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Plxna4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLXNA4 mRNA | CTD | PMID:36331819 | PLXNA4 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of PLXNA4 mRNA | CTD | PMID:25812627 | PLXNA4 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of PLXNA4 mRNA | CTD | PMID:26272509 | PLXNA4 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXNA4 mRNA | CTD | PMID:27188386 | PLXNA4 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXNA4 mRNA | CTD | PMID:27188386 | PLXNA4 | Human | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of PLXNA4 mRNA | CTD | PMID:34032870 | PLXNA4 | Human | sodium arsenite | decreases expression | ISO | Plxna4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PLXNA4 mRNA | CTD | PMID:36209798 | PLXNA4 | Human | sodium arsenite | increases expression | ISO | Plxna4 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of PLXNA4 mRNA | CTD | PMID:37682722 | PLXNA4 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of PLXNA4 mRNA | CTD | PMID:31533062 | PLXNA4 | Human | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of PLXNA4 mRNA | CTD | PMID:31863870 | PLXNA4 | Human | thioacetamide | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of PLXNA4 mRNA | CTD | PMID:34492290 | PLXNA4 | Human | titanium dioxide | decreases methylation | ISO | Plxna4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PLXNA4 gene | CTD | PMID:35295148 | PLXNA4 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of PLXNA4 mRNA | CTD | PMID:37042841 | PLXNA4 | Human | valproic acid | affects expression | ISO | Plxna4 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PLXNA4 mRNA | CTD | PMID:17292431 | PLXNA4 | Human | valproic acid | decreases expression | ISO | Plxna4 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of PLXNA4 mRNA | CTD | PMID:29427782 | PLXNA4 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of PLXNA4 mRNA | CTD | PMID:27188386 | |